Cited by 304MicroRNA in disease regulationThyroid Cancer Diagnosis and TreatmentCancer-related molecular mechanisms research

Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer

Open access
Jazdzewski, Krystian, Liyanarachchi, Sandya, Swierniak, Michal, Pachucki, Janusz, Ringel, Matthew D., Jarzab, Barbara, de la Chapelle, Albert·2009·Proceedings of the National Academy of Sciences

Abstract

Prior work has shown that heterozygosity G/C of single nucleotide polymorphism (SNP rs2910164) within the precursor of microRNA-146a predisposes to PTC (odds ratio = 1.62, P = 0.000007) although the mechanism was unclear. Here, we show that GC heterozygotes differ from both GG and CC homozygotes by producing 3 mature microRNAs: 1 from the leading strand (miR-146a), and 2 from the passenger strand (miR-146a*G and miR-146a*C), each with its distinct set of target genes. TaqMan analysis of paired tumor/normal samples revealed 1.5- to 2.6-fold overexpression of polymorphic miR-146a* in 7 of 8 tumors compared with the unaffected part of the same gland. The microarray data showed that widely different transcriptomes occurred in the tumors and in unaffected parts of the thyroid from GC and GG patients. The modulated genes are mainly involved in regulation of apoptosis leading to exaggerated DNA-damage response in heterozygotes potentially explaining the predisposition to cancer. We propose that contrary to previously held views transcripts from the passenger strand of miRs can profoundly affect the downstream effects. Heterozygosity for polymorphisms within the premiR sequence can cause epistasis through the production of additional mature miRs. We propose that mature miRs from the passenger strand may regulate many genetic processes.

Integrity signals

Registry

Crossref · 10.1073/pnas.0812591106

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A SNP within miR-146a that confers increased risk of thyroid cancer hinders pre-miRNA processing and affects the seed region of the companion miR-146a*.

    “Interestingly, one SNP within the miR-146a, which confers an increased risk to develop thyroid cancer, not only hindered the pre-miRNA processing, but also affected the seed region of the companion miR-146a*, similarly to the miR-96(+57T>C) mutation.”
  • miR-146a* is expressed in both normal and tumor thyroid tissues, and altered regulation of miRNA* targets in heterozygotes compared with homozygotes was suggested as a possible mechanism underlying tumor predisposition.

    “The miR-146a* was expressed in both normal and tumor thyroid tissues and the altered regulation of the miRNA* targets in heterozygotes compared with homozygotes was suggested as the possible mechanism underlying tumor predisposition (26).”
  • A G/C polymorphism in the miR-146a locus is associated with papillary thyroid carcinoma (PTC) progression.

    “In other examples, a G/C polymorphism in the miR‐146a locus, associated with papillary thyroid carcinoma (PTC) progression, alters the sequence of miR‐146a* (3p) strand, and likely leads to changes in target repression, contributing to PTC (Jazdzewski et al., 2009; Labbaye & Testa, 2012), (Table 1).”

    From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Jazdzewski et al., 2009

  • The G/C polymorphism alters the sequence of miR-146a* (3p) strand and likely leads to changes in target repression, contributing to PTC.

    “alters the sequence of miR‐146a* (3p) strand, and likely leads to changes in target repression, contributing to PTC (Jazdzewski et al., 2009; Labbaye & Testa, 2012), (Table 1).”

    From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Jazdzewski et al., 2009

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jazdzewski, K., Liyanarachchi, S., Swierniak, M., Pachucki, J., Ringel, M. D., Jarzab, B., & de la Chapelle, A.
Affiliations
  • Human Cancer Genetics Program, Comprehensive Cancer Center and
  • Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 44-101 Gliwice, Poland; and
  • Medical University of Warsaw (PL)
  • The Ohio State University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2009-02-03
Volume
106
Issue
5
Pages
1502-1505
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1980735015
Cited by
304
References
3
Citations by year
2025: 1 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 12 · 2018: 14 · 2017: 14 · 2016: 16 · 2015: 24 · 2014: 36 · 2013: 38 · 2012: 33
FWCI
12.53
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ohio State University (CA16058)
  • National Cancer Institute (CA124570, CA16058, P01CA124570, P30CA016058)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
microRNA-146a, miR-146a, thyroid cancer, papillary thyroid carcinoma, genetic susceptibility, heterozygosity, epistasis, apoptosis regulation, DNA damage response, miRNA target genes, transcriptome
MeSH terms
Base Sequence, Heterozygote, Humans, RNA Precursors, RNA, Messenger, Thyroid Neoplasms, Apoptosis, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, MicroRNAs, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review